FDA Inspection 1315610 — Northwest Center For Infertility And Reproductive Endocrinology
The FDA completed an inspection of Northwest Center For Infertility And Reproductive Endocrinology on Apr 14, 2026 in Jacksonville, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 14, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Jacksonville, FL (United States)